Literature DB >> 21454801

An extracellular signal-regulated kinase 2 survival pathway mediates resistance of human mesothelioma cells to asbestos-induced injury.

Arti Shukla1, Trisha F Barrett, Maximilian B MacPherson, Jedd M Hillegass, Naomi K Fukagawa, William A Swain, Kenneth J O'Byrne, Joseph R Testa, Harvey I Pass, Stephen P Faux, Brooke T Mossman.   

Abstract

We hypothesized that normal human mesothelial cells acquire resistance to asbestos-induced toxicity via induction of one or more epidermal growth factor receptor (EGFR)-linked survival pathways (phosphoinositol-3-kinase/AKT/mammalian target of rapamycin and extracellular signal-regulated kinase [ERK] 1/2) during simian virus 40 (SV40) transformation and carcinogenesis. Both isolated HKNM-2 mesothelial cells and a telomerase-immortalized mesothelial line (LP9/TERT-1) were more sensitive to crocidolite asbestos toxicity than an SV40 Tag-immortalized mesothelial line (MET5A) and malignant mesothelioma cell lines (HMESO and PPM Mill). Whereas increases in phosphorylation of AKT (pAKT) were observed in MET5A cells in response to asbestos, LP9/TERT-1 cells exhibited dose-related decreases in pAKT levels. Pretreatment with an EGFR phosphorylation or mitogen-activated protein kinase kinase 1/2 inhibitor abrogated asbestos-induced phosphorylated ERK (pERK) 1/2 levels in both LP9/TERT-1 and MET5A cells as well as increases in pAKT levels in MET5A cells. Transient transfection of small interfering RNAs targeting ERK1, ERK2, or AKT revealed that ERK1/2 pathways were involved in cell death by asbestos in both cell lines. Asbestos-resistant HMESO or PPM Mill cells with high endogenous levels of ERKs or AKT did not show dose-responsive increases in pERK1/ERK1, pERK2/ERK2, or pAKT/AKT levels by asbestos. However, small hairpin ERK2 stable cell lines created from both malignant mesothelioma lines were more sensitive to asbestos toxicity than shERK1 and shControl lines, and exhibited unique, tumor-specific changes in endogenous cell death-related gene expression. Our results suggest that EGFR phosphorylation is causally linked to pERK and pAKT activation by asbestos in normal and SV40 Tag-immortalized human mesothelial cells. They also indicate that ERK2 plays a role in modulating asbestos toxicity by regulating genes critical to cell injury and survival that are differentially expressed in human mesotheliomas.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21454801      PMCID: PMC3262687          DOI: 10.1165/rcmb.2010-0282OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  48 in total

Review 1.  The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions.

Authors:  Seunghee Yoon; Rony Seger
Journal:  Growth Factors       Date:  2006-03       Impact factor: 2.511

2.  Phosphorylated extracellular signal-regulated kinases are significantly increased in malignant mesothelioma.

Authors:  Merivane de Melo; Margaret W Gerbase; Joseph Curran; Jean-Claude Pache
Journal:  J Histochem Cytochem       Date:  2006-03-03       Impact factor: 2.479

3.  Mechanisms linking adenosine A1 receptors and extracellular signal-regulated kinase 1/2 activation in human trabecular meshwork cells.

Authors:  S Husain; T W Shearer; C E Crosson
Journal:  J Pharmacol Exp Ther       Date:  2006-10-02       Impact factor: 4.030

4.  Crocidolite asbestos and SV40 are cocarcinogens in human mesothelial cells and in causing mesothelioma in hamsters.

Authors:  Barbara Kroczynska; Rochelle Cutrone; Maurizio Bocchetta; Haining Yang; Amira G Elmishad; Pamela Vacek; Maria Ramos-Nino; Brooke T Mossman; Harvey I Pass; Michele Carbone
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-11       Impact factor: 11.205

5.  Association of SV40 with human tumors.

Authors:  George Klein; Amy Powers; Carlo Croce
Journal:  Oncogene       Date:  2002-02-14       Impact factor: 9.867

6.  Human and mouse mesotheliomas exhibit elevated AKT/PKB activity, which can be targeted pharmacologically to inhibit tumor cell growth.

Authors:  Deborah A Altomare; Huihong You; Guang-Hui Xiao; Maria E Ramos-Nino; Kristine L Skele; Assunta De Rienzo; Suresh C Jhanwar; Brooke T Mossman; Agnes B Kane; Joseph R Testa
Journal:  Oncogene       Date:  2005-09-08       Impact factor: 9.867

7.  Human mesothelioma cells exhibit tumor cell-specific differences in phosphatidylinositol 3-kinase/AKT activity that predict the efficacy of Onconase.

Authors:  Maria E Ramos-Nino; Giovina Vianale; Tara Sabo-Attwood; Luciano Mutti; Camilo Porta; Nicholas Heintz; Brooke T Mossman
Journal:  Mol Cancer Ther       Date:  2005-05       Impact factor: 6.261

8.  Alterations in gene expression in human mesothelial cells correlate with mineral pathogenicity.

Authors:  Arti Shukla; Maximilian B MacPherson; Jedd Hillegass; Maria E Ramos-Nino; Vlada Alexeeva; Pamela M Vacek; Jeffrey P Bond; Harvey I Pass; Chad Steele; Brooke T Mossman
Journal:  Am J Respir Cell Mol Biol       Date:  2008-12-18       Impact factor: 6.914

9.  The effect of an antisense expression plasmid to the IGF-1 receptor on hamster mesothelioma proliferation.

Authors:  H I Pass; D J Mew; M Carbone; J S Donington; R Baserga; S M Steinberg
Journal:  Dev Biol Stand       Date:  1998

Review 10.  The role of growth factors and cytokines in the tumorigenesis and immunobiology of malignant mesothelioma.

Authors:  D R Fitzpatrick; D J Peroni; H Bielefeldt-Ohmann
Journal:  Am J Respir Cell Mol Biol       Date:  1995-05       Impact factor: 6.914

View more
  7 in total

1.  Nickel nanoparticles enhance platelet-derived growth factor-induced chemokine expression by mesothelial cells via prolonged mitogen-activated protein kinase activation.

Authors:  Ellen E Glista-Baker; Alexia J Taylor; Brian C Sayers; Elizabeth A Thompson; James C Bonner
Journal:  Am J Respir Cell Mol Biol       Date:  2012-06-14       Impact factor: 6.914

2.  Malignant mesothelioma: development to therapy.

Authors:  Joyce K Thompson; Catherine M Westbom; Arti Shukla
Journal:  J Cell Biochem       Date:  2014-01       Impact factor: 4.429

3.  Identification of novel COX-2 / CYP19A1 axis involved in the mesothelioma pathogenesis opens new therapeutic opportunities.

Authors:  Barbara Nuvoli; Barbara Antoniani; Roberta Libener; Antonio Maconi; Andrea Sacconi; Mariantonia Carosi; Rossella Galati
Journal:  J Exp Clin Cancer Res       Date:  2021-08-17

4.  Massive localized malignant pleural mesothelioma (LMPM): manifestations on computed tomography in 6 cases.

Authors:  Weigen Yao; Hanqing Yang; Guolai Huang; Yang Yan; Honglin Wang; Dongfang Sun
Journal:  Int J Clin Exp Med       Date:  2015-10-15

5.  Increasing dietary selenium elevates reducing capacity and ERK activation associated with accelerated progression of select mesothelioma tumors.

Authors:  Aaron H Rose; Pietro Bertino; FuKun W Hoffmann; Giovanni Gaudino; Michele Carbone; Peter R Hoffmann
Journal:  Am J Pathol       Date:  2014-02-01       Impact factor: 4.307

6.  Gene expression profiling of homologous recombination repair pathway indicates susceptibility for olaparib treatment in malignant pleural mesothelioma in vitro.

Authors:  Sabrina Borchert; Michael Wessolly; Jan Schmeller; Elena Mairinger; Jens Kollmeier; Thomas Hager; Thomas Mairinger; Thomas Herold; Daniel C Christoph; Robert F H Walter; Wilfried E E Eberhardt; Till Plönes; Jeremias Wohlschlaeger; Clemens Aigner; Kurt Werner Schmid; Fabian D Mairinger
Journal:  BMC Cancer       Date:  2019-01-30       Impact factor: 4.430

7.  Cancer-Associated Fibroblasts Regulate Kinase Activity in Mesothelioma Cell Lines via Paracrine Signaling and Thereby Dictate Cell Faith and Behavior.

Authors:  Alexander Mathilakathu; Michael Wessolly; Elena Mairinger; Hendrik Uebner; Daniel Kreidt; Luka Brcic; Julia Steinborn; Kristina Greimelmaier; Jeremias Wohlschlaeger; Kurt Werner Schmid; Fabian D Mairinger; Sabrina Borchert
Journal:  Int J Mol Sci       Date:  2022-03-18       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.